bioRxivBiophysicsPreprint
The flow of sickle blood through glass capillaries: a point of care application
Abstract
We show that the characteristic time for sickled blood to traverse 100 {micro}m-diameter glass capillaries can be used as the foundation for a useful point-of-care diagnosis for sickle cell disease. 3.2 cm long capillaries were inserted into a 5 {micro}L drop of blood, and 1/4 {micro}L was spontaneously drawn into the tube. The rate at which the blood traversed the capillary was significantly changed by deoxygenation only for sickle genotypes, a consequence of the increased viscosity of cells containing sickle fibers. Under these conditions, we find deoxygenation causes the time for sickle blood to traverse the capillary to increase to about 3 times its original value, in contrast to normal blood, where the times are equivalent regardless of state of oxygenation. This corresponds to readily-observed time differences of around 10 s for capillary traversal. Such changes are present for blood from homozygous sickle cell patients, as well as heterozygous patients with hemoglobin AS, SC, and S{beta}+ thalassemia. Moreover, we demonstrate that this test is sensitive to sickling therapies that increase the production of fetal Hb. This viscosity-based measurement thus offers the prospect of an assay that is 10 times faster than any current test of which we are aware, at costs that rival the least expensive of any current assays.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Electrical impedance detection of sickle cell vaso-occlusion in microfluidic capillary structures
- Smartphone-based Sickle Cell Disease Detection and Monitoring for Point-of-Care Settings
- Suspension physics govern the multiscale dynamics of blood flow in sickle cell disease
Hannah M. Szafraniec, Freya Bull, … David K. Wood·Science AdvancesPeer-reviewed·Jan 1, 2026
- Soluble LIGHT (TNFSF14) activates endothelial cells, thereby priming the first vessel-occlusive events in acute sickle cell disease
P. Chadebech, K.-A. Nguyen-Peyre, … P. Bartolucci·bioRxiv·Jun 8, 2023
- Spontaneous development of cerebrovascular pathology and microinfarcts in a mouse model of sickle cell disease.
Hyacinth I. Hyacinth, Courtney L Sugihara, … Andy Y. Shih·Journal of Cerebral Blood Flow & MetabolismPeer-reviewed·Sep 19, 2017
- A portable molecular laboratory for rapid genotyping in the field: application to sickle cell disease
Fabienne Grunder, Anne-Flore Hämmerli, … Hugues Abriel·medRxiv·May 12, 2026